Lifeboat Foundation

A protein that has been widely studied owing to its association with neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) is also linked to medulloblastoma, a type of central nervous system cancer. Medulloblastoma is one of the most common and aggressive brain tumors in children, arising from undifferentiated cells during early neural development.

A study led by a group of Brazilian scientists has shown in vitro and in vivo that the gene VAPB is linked to cell proliferation in these tumors. An article on the study is published in the journal Scientific Reports.

The discovery points to a potential marker of severity and, after more research, a future therapeutic target. Medulloblastoma is currently treated with a combination of surgery to remove the tumor and radiation therapy and/or chemotherapy, both of which are aggressive and can cause long-lasting brain damage.

A common practice of prescribing anticoagulants to people who have had unexplained strokes should stop, according to a study led by researchers at Columbia, Weill Cornell Medicine, and the University of Washington and published in JAMA.

Anticoagulants were thought to prevent additional strokes in people whose initial stroke has an unknown cause but who have a heart condition, atrial cardiopathy, that resembles atrial fibrillation, a common cause of stroke.

“We know these drugs work for people with atrial fibrillation, so we thought that they would probably work for people with atrial cardiopathy as well,” says Mitchell Elkind, MD, professor of neurology at the Vagelos College of Physicians and Surgeons and one of the study’s leaders. “That was the basis for the trial.”

Tissue contamination distracts AI models from making accurate real-world diagnoses. Human pathologists are extensively trained to detect when tissue samples from one patient mistakenly end up on another patient’s microscope slides (a problem known as tissue contamination). But such contamination can easily confuse artificial intelligence (AI) models, which are often trained in pristine, simulated environments, reports a new Northwestern Medicine study.

“We train AIs to tell ‘A’ versus ‘B’ in a very clean, artificial environment, but, in real life, the AI will see a variety of materials that it hasn’t trained on. When it does, mistakes can happen,” said corresponding author Dr. Jeffery Goldstein, director of perinatal pathology and an assistant professor of perinatal pathology and autopsy at Northwestern University Feinberg School of Medicine.

“Our findings serve as a reminder that AI that works incredibly well in the lab may fall on its face in the real world. Patients should continue to expect that a human expert is the final decider on diagnoses made on biopsies and other tissue samples. Pathologists fear — and AI companies hope — that the computers are coming for our jobs. Not yet.”

A study at the University of Cologne’s CECAD Cluster of Excellence in Aging Research has identified a protein complex that is activated by defects in the spliceosome, the molecular scissors that process genetic information. Future research could lead to new therapeutic approaches to treat diseases caused by faulty splicing.

The genetic material, in the form of DNA, contains the information that is crucial for the correct functioning of every human and animal cell. From this information repository, RNA, an intermediate between DNA and protein, the functional unit of the cell, is generated. During this process, the genetic information must be tailored for specific cell functions. Information that is not needed (introns) is cut out of the RNA and the important components for proteins (exons) are preserved.

A team of researchers led by Professor Dr. Mirka Uhlirova at the University of Cologne’s CECAD Cluster of Excellence in Aging Research has now discovered that if the processing of this information no longer works properly, a protein complex (C/EBP heterodimer) is activated and directs the cell towards a dormant state, known as cellular senescence. The results appear under the title “Xrp1 governs the stress response program to spliceosome dysfunction” in Nucleic Acids Research.

Scientists have been making nanoparticles out of DNA strands for two decades, manipulating the bonds that maintain DNA’s double-helical shape to sculpt self-assembling structures that could someday have jaw-dropping medical applications.

The study of DNA nanoparticles, however, has focused mostly on their architecture, turning the genetic code of life into components for fabricating minuscule robots. A pair of Iowa State University researchers in the genetics, development, and cell biology department—professor Eric Henderson and recent doctoral graduate Chang-Yong Oh—hope to change that by showing nanoscale materials made of DNA can convey their built-in genetic instructions.

“So far, most people have been exploring DNA nanoparticles from an engineering perspective. Little attention has been paid to the information held in those DNA strands,” Oh said.

Researchers have created the first functional 3D-printed brain tissue that can develop and form connections in the same way as real human brain tissue.

This remarkable accomplishment by a team at the University of Wisconsin–Madison provides neuroscientists with a new tool for studying communication between brain cells and other parts of the human brain, potentially leading to better ways of treating diseases like Alzheimer’s and Parkinson’s.

Continue reading “World’s First 3D-Printed Neural Tissue Grows And Functions Like a Human Brain” »

THURSDAY, Feb. 1, 2024 (HealthDay News) — Drug overdoses resulting in cardiac arrest occur most often among young adults, a new study finds.

People tend to have OD-related cardiac arrests at an average age of 39, compared to an average age of 64 for those suffering cardiac arrests not related to opioids, results show.

“Many communities face ongoing challenges with increases in drug overdoses, which tend to affect a younger, healthier population,” said lead researcher Aditya Shekhar, a medical student at the Icahn School of Medicine at Mount Sinai in New York City.

An international team of researchers has identified the genetic basis and biological processes that influence cancer risk related to alterations in the number of immune cells present in the blood. This is a significant advance in understanding how the immune system can prevent the appearance of tumors.

The study, led by researchers from the Institut Català d’Oncologia (ICO), the Bellvitge Biomedical Research Institute (IDIBELL), the Germans Trias i Pujol Research Institute (IGTP), and the Translational Genomics Research Institute in the United States, has been published in the journal Genome Medicine and represents a significant step towards a better understanding of how alterations in the immune system facilitate the onset of cancer.

The immune system is responsible for maintaining the integrity and function of the body by continuously protecting us from exogenous attacks, such as viruses and endogenous attacks, in this case, cancer. This gives it a central role in inhibiting carcinogenesis, and its disruption may increase the risk of cancer by allowing malignant cells to proliferate.

Deep learning #AI for skin lesions assessed for assistance to 800 dermatologists and primary care physicians from 39 countries Marked improvement in accuracy but widened bias gap.

In a large-scale study involving 389 board-certified dermatologists and 459 primary-care physicians from 39 countries, the impact of a deep learning-aided decision support system on physicians’ diagnostic accuracy was tested across 46 skin diseases and for both light and dark skin tones.